Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19
Richard Ro, Sahil Khera, Gilbert H.L. Tang, Parasuram Krishnamoorthy, Samin K. Sharma, Annapoorna Kini, Stamatios Lerakis
Abstract
This cohort study examines the characteristics and outcomes of patients for whom transcatheter aortic valve replacement (TAVR) was deferred because of the coronavirus disease 2019 (COVID-19) pandemic.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Valve replacementCardiologyMedicineInternal medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Aortic valve replacementVirologyStenosisDiseaseOutbreakInfectious disease (medical specialty)Cardiac Valve Diseases and TreatmentsInfective Endocarditis Diagnosis and ManagementCOVID-19 and healthcare impacts